Ameritas Investment Partners, Inc. - MERIDIAN BIOSCIENCE INC ownership

MERIDIAN BIOSCIENCE INC's ticker is VIVO and the CUSIP is 589584101. A total of 178 filers reported holding MERIDIAN BIOSCIENCE INC in Q3 2018. The put-call ratio across all filers is 0.13 and the average weighting 0.0%.

Quarter-by-quarter ownership
Ameritas Investment Partners, Inc. ownership history of MERIDIAN BIOSCIENCE INC
ValueSharesWeighting
Q4 2022$109,165
+8.1%
3,2240.0%0.00%
-20.0%
Q3 2022$101,000
+3.1%
3,2240.0%0.01%
+25.0%
Q2 2022$98,000
+6.5%
3,224
-9.3%
0.00%
+33.3%
Q1 2022$92,000
+26.0%
3,5560.0%0.00%
+50.0%
Q4 2021$73,000
+7.4%
3,5560.0%0.00%0.0%
Q3 2021$68,000
-13.9%
3,5560.0%0.00%
-33.3%
Q2 2021$79,000
-15.1%
3,5560.0%0.00%
-25.0%
Q1 2021$93,000
+40.9%
3,5560.0%0.00%
+33.3%
Q4 2020$66,000
+10.0%
3,5560.0%0.00%0.0%
Q3 2020$60,000
-27.7%
3,5560.0%0.00%
-25.0%
Q2 2020$83,000
+176.7%
3,5560.0%0.00%
+100.0%
Q1 2020$30,000
-14.3%
3,5560.0%0.00%0.0%
Q4 2019$35,000
+2.9%
3,5560.0%0.00%0.0%
Q3 2019$34,000
-19.0%
3,5560.0%0.00%0.0%
Q2 2019$42,000
-33.3%
3,5560.0%0.00%
-33.3%
Q1 2019$63,000
+1.6%
3,5560.0%0.00%0.0%
Q4 2018$62,000
+17.0%
3,5560.0%0.00%
+50.0%
Q3 2018$53,000
-7.0%
3,5560.0%0.00%
-33.3%
Q2 2018$57,000
+14.0%
3,5560.0%0.00%
+50.0%
Q1 2018$50,0000.0%3,5560.0%0.00%0.0%
Q4 2017$50,000
+2.0%
3,5560.0%0.00%0.0%
Q3 2017$49,000
-12.5%
3,5560.0%0.00%
-33.3%
Q2 2017$56,000
+14.3%
3,5560.0%0.00%
+50.0%
Q1 2017$49,000
-93.3%
3,556
-91.4%
0.00%
-96.2%
Q3 2014$734,000
-14.3%
41,5000.0%0.05%
-14.5%
Q2 2014$856,00041,5000.06%
Other shareholders
MERIDIAN BIOSCIENCE INC shareholders Q3 2018
NameSharesValueWeighting ↓
Euclidean Technologies Management, LLC 115,571$3,034,0002.64%
Acuitas Investments, LLC 160,046$4,201,0002.41%
HUSSMAN STRATEGIC ADVISORS, INC. 144,000$3,780,0000.78%
GLOBEFLEX CAPITAL L P 158,664$4,165,0000.76%
CLARK ESTATES INC/NY 220,000$5,775,0000.74%
SYSTEMATIC FINANCIAL MANAGEMENT LP 721,176$18,931,0000.69%
EARNEST PARTNERS LLC 4,341,834$113,973,0000.68%
MOODY ALDRICH PARTNERS LLC 138,844$3,645,0000.53%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 889,269$23,343,0000.49%
Phocas Financial Corp. 134,740$3,537,0000.47%
View complete list of MERIDIAN BIOSCIENCE INC shareholders